US Patent 7829096 CD40L-specific monovalent polypeptides
Patent 7829096 was granted and assigned to Domantis Limited on November, 2010 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7829096 CD40L-specific monovalent polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.